Wird geladen...
US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer
PURPOSE: National guidelines recommend a 21-gene recurrence score (RS) to aid in adjuvant treatment decision in patients with estrogen receptor (ER) –positive, lymph node (LN) –negative early-stage breast cancer (ESBC). This study was performed to assess the economic implication of the assay in comm...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Clinical Oncology
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3092466/ https://ncbi.nlm.nih.gov/pubmed/21886510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000303 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|